Tetra Pharm Technologies advances CB1 antagonist, TPT0701, for appetite suppression Tetra Pharm Technologies has reached a significant in developing its compound for appetite suppression, TPT0701, following the successful...
Tirzepatide found to reduce body weight regardless of duration of condition and BMI before treatment4 days ago